Sava Infond D.O.O. Natera, Inc. Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Natera, Inc. stock. As of the latest transaction made, Sava Infond D.O.O. holds 4,000 shares of NTRA stock, worth $552,520. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$552,520
Previous $566 Million
19.47%
% of portfolio
0.11%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
676Shares Held
126MCall Options Held
982KPut Options Held
1.14M-
Vanguard Group Inc Valley Forge, PA12.4MShares$1.71 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.46 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.02 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$935 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$628 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $13.4B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...